HIT 2.0: an enhanced platform for Herbal Ingredients' Targets

Author:

Yan Deyu1ORCID,Zheng Genhui1ORCID,Wang Caicui1,Chen Zikun1,Mao Tiantian1,Gao Jian23,Yan Yu1,Chen Xiangyi1,Ji Xuejie1,Yu Jinyu1,Mo Saifeng1,Wen Haonan1,Han Wenhao1,Zhou Mengdi1,Wang Yuan1,Wang Jun1,Tang Kailin1ORCID,Cao Zhiwei4

Affiliation:

1. Dept. of Gastroenterology, Shanghai Tenth People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China

2. International Human Phenome Institutes (Shanghai), Shanghai, China

3. Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China

4. School of Life Sciences, Fudan University, Shanghai 200092, China

Abstract

Abstract Literature-described targets of herbal ingredients have been explored to facilitate the mechanistic study of herbs, as well as the new drug discovery. Though several databases provided similar information, the majority of them are limited to literatures before 2010 and need to be updated urgently. HIT 2.0 was here constructed as the latest curated dataset focusing on Herbal Ingredients’ Targets covering PubMed literatures 2000–2020. Currently, HIT 2.0 hosts 10 031 compound-target activity pairs with quality indicators between 2208 targets and 1237 ingredients from more than 1250 reputable herbs. The molecular targets cover those genes/proteins being directly/indirectly activated/inhibited, protein binders, and enzymes substrates or products. Also included are those genes regulated under the treatment of individual ingredient. Crosslinks were made to databases of TTD, DrugBank, KEGG, PDB, UniProt, Pfam, NCBI, TCM-ID and others. More importantly, HIT enables automatic Target-mining and My-target curation from daily released PubMed literatures. Thus, users can retrieve and download the latest abstracts containing potential targets for interested compounds, even for those not yet covered in HIT. Further, users can log into ‘My-target’ system, to curate personal target-profiling on line based on retrieved abstracts. HIT can be accessible at http://hit2.badd-cao.net.

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Oxford University Press (OUP)

Subject

Genetics

Reference25 articles.

1. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019;Newman;J. Nat. Prod.,2020

2. Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics;Wang;Nucleic Acids Res,2020

3. DrugBank 5.0: a major update to the DrugBank database for 2018;Wishart;Nucleic Acids Res,2018

4. Uncovering the mechanisms of cryptotanshinone as a therapeutic agent against hepatocellular carcinoma;Luo;Front. Pharmacol.,2020

5. Discovery of potential asthma targets based on the clinical efficacy of Traditional Chinese Medicine formulas;Wang;J. Ethnopharmacol.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3